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ABSTRACT
Motivation: The sequencing of the human genome has made it
possible to identify an informative set of >1 million single nucleotide
polymorphisms (SNPs) across the genome that can be used to carry
out genome-wide association studies (GWASs). The availability of
massive amounts of GWAS data has necessitated the development
of new biostatistical methods for quality control, imputation and
analysis issues including multiple testing. This work has been
successful and has enabled the discovery of new associations
that have been replicated in multiple studies. However, it is now
recognized that most SNPs discovered via GWAS have small effects
on disease susceptibility and thus may not be suitable for improving
health care through genetic testing. One likely explanation for the
mixed results of GWAS is that the current biostatistical analysis
paradigm is by design agnostic or unbiased in that it ignores all prior
knowledge about disease pathobiology. Further, the linear modeling
framework that is employed in GWAS often considers only one SNP
at a time thus ignoring their genomic and environmental context.
There is now a shift away from the biostatistical approach toward
a more holistic approach that recognizes the complexity of the
genotype–phenotype relationship that is characterized by signiﬁcant
heterogeneity and gene–gene and gene–environment interaction.
We argue here that bioinformatics has an important role to play in
addressingthecomplexityoftheunderlyinggeneticbasisofcommon
human diseases. The goal of this review is to identify and discuss
those GWAS challenges that will require computational methods.
Contact: jason.h.moore@dartmouth.edu
1 INTRODUCTION
The current strategy for revealing the genetic basis of disease
susceptibility is to carry out a genome-wide association study
(GWAS) with a million or more single nucleotide polymorphisms
(SNPs) that capture much of the common variation in the human
genome (Hirscchorn et al., 2005; Wang et al., 2005). This approach
is based on the idea that genetic variations with alleles that are
common in the population will explain much of the heritability
of common diseases (Reich and Lander, 2001). This is referred to
as the common disease common variant hypothesis and has been
recently reviewed by Schork et al. (2009). These studies were made
possible by the sequencing of the human genome (International
Human Genome Sequencing Consortium, 2004) and the completion
of the subsequent human haplotype mapping (HapMap) project
∗To whom correspondence should be addressed.
that discovered millions of common SNPs and documented the
correlation structure or linkage disequilibrium of the alleles at those
loci(TheInternationalHapMapConsortium,2005).Thisknowledge
about genome variation in combination with novel bioengineering
methods made it possible to design chips for measuring more than
a million SNPs for several hundred dollars or less per sample. As
the price of genome-wide genotyping has dropped, the number of
studiesutilizingGWAShasincreaseddramaticallyandthisapproach
is now relatively common. As Manolio et al. (2008) and Donnelly
(2008) have recently reviewed, hundreds of replicated susceptibility
loci for as many as 70 diseases and traits have been reported from
GWAS. Unfortunately, despite high expectations, few of the loci
identiﬁedviaGWASareassociatedwithamoderateorlargeincrease
in disease risk and some well-known genetic risk factors have been
missed (Williams et al., 2007). In fact, the relative risks of most
new loci are on the order of 1.1 to 1.2 at best which suggests that
these individual SNPs may not be useful for genetic testing. This
limitation has been pointed out in a recent study by Jakobsdottir
et al. (2009) that showed SNPs identiﬁed by GWAS for a variety of
diseases make very poor classiﬁers of disease, calling into question
their usefulness for risk assessment in personal genetics (Moore and
Williams, 2009).
To illustrate successes and failures of GWAS, consider the
following review of breast, prostate, colorectal, lung and skin cancer
that shows that a number of new susceptibility loci have been
identiﬁed using the GWAS approach (Easton and Eeles, 2008). As
mentioned above, the loci identiﬁed by GWAS typically have very
small effect sizes. This is true for cancer where the increase in risk
for the susceptibility alleles at each of the loci discovered by GWAS
is generally 1.3-fold or less. Let us ﬁrst consider familial breast
cancer as a rare disease that has a very high heritability and is thus
believed to have a relatively simple etiology. Easton et al. (2007)
reported ﬁve signiﬁcant, replicated associations that were identiﬁed
byGWASandreplicatedinseveralindependentsamplesofsubjects.
Four of the discovered variants were in known genes and one was
located in a hypothetical gene. Assuming a multiplicative model,
these ﬁve loci together explain only 3.6% of the excess familial risk
of breast cancer. Due to these small effect sizes, Ripperger et al.
(2009) concluded that these loci are not suitable for use in genetic
testing.Inafollow-upstudywithtwoadditionalstagesoftestingand
replication, two additional susceptibility loci were identiﬁed with
odds ratios of 1.11 and 0.95, respectively. These two loci account
for much <1% of the familial risk of breast cancer (Ahmed et al.,
2009).When combined with the previous known genetic risk factors
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for familial breast cancer, the estimated fraction of risk explained is
∼5.9%. This is in stark contrast to BRCA1 and BRCA2 mutations
that together account for between 20 and 40% of familial breast
cancer. While the application of GWAS to familial breast cancer
has generated new knowledge and perhaps new biology, it has not
resulted in new genetic tests that can be used to predict and prevent
familial breast cancer. The results for common diseases such as
sporadic breast cancer and type II diabetes that have a much more
complex underlying genetic architecture are similarly discouraging.
As another example, consider a recent GWAS applied to
pancreatic cancer. Amundadottir et al. (2009) measured >500000
SNPs in a detection sample of 1896 patients with pancreatic cancer
and1939controlsascertainedfromthesamepopulationasthecases.
The authors also used a replication sample of 2457 cases and 2654
controls. A logistic regression analysis of both samples identiﬁed a
single SNP with an odds ratio of 1.2. This single SNP was located
in an intron of the ABO blood group gene. This result conﬁrmed
previous epidemiological studies showing that the O blood group
is associated with a lower risk of pancreatic cancer. Interestingly,
this association was ﬁrst reported >50 years ago and thus does not
represent a novel ﬁnding. The failure to identify new susceptibility
loci for some diseases using GWAS in relatively large sample sizes
highlights some of the limitations of this approach.
These studies and many others highlight the positive and negative
aspects of GWAS for common diseases and complex traits. One
explanation for the mixed results of GWAS is that the current
biostatistical analysis paradigm is, by design, agnostic or unbiased
in that it ignores what is known about disease pathobiology.
Further, the linear modeling framework often used for GWAS
analysis usually considers only one SNP at a time thus ignoring
the genomic and environmental context of each SNP (Moore and
Williams, 2009). As Clark et al. (2004) predicted, our success
with GWAS depends critically on the assumptions we make
about disease complexity. Recently, there has been a shift away
from the one SNP at a time approach toward a more holistic
approach that recognizes the complexity of the genotype–phenotype
relationship that is likely characterized by signiﬁcant genetic
heterogeneity and gene–gene and gene–environment interaction.
We argue here that bioinformatics can play an important role in
addressing the complexity of the underlying genetic basis of many
common human diseases. The goal of this review is to identify
and discuss those GWAS challenges that require computational
rather than, or in addition to, biostatistical methods. We focus
on computational methods for data mining and machine learning
and bioinformatics methods for incorporating prior biological
knowledge into data analysis algorithms. We conclude with a
discussion about maximizing the utility of bioinformatics software
for GWAS analysis. Readers are directed elsewhere for recent
reviews of GWAS study design, quality control, imputation and
biostatistical analysis issues (e.g.Amos, 2007; Chanock et al., 2007;
Kraft and Cox, 2008; Spencer et al., 2009; Ziegler et al., 2008).
2 DATA MINING AND MACHINE LEARNING
2.1 Why are data mining and machine learning
methods needed?
An important goal of human genetics and genetic epidemiology
is to understand the mapping relationship between interindividual
variation in DNA sequences, variation in environmental exposure
and variation in disease susceptibility. Stated another way, how do
one or more changes in an individual’s DNA sequence increase or
decrease their risk of developing disease through complex networks
of biomolecules that are hierarchically organized, highly interactive
and dependent on environmental exposures? Understanding the
role of genomic variation and environmental context in disease
susceptibility is likely to improve diagnosis, prevention and
treatment. Success in this important public health endeavor will
depend critically on the amount of non-linearity in the mapping
of genotype to phenotype and our ability to address it. Here, we
deﬁne as non-linear an outcome that cannot be easily predicted by
the sum of the individual genetic markers. Non-linearities can arise
from phenomena such as locus heterogeneity (i.e. different DNA
sequence variations leading to the same phenotype), phenocopy (i.e.
environmentally determined phenotypes that do not have a genetic
basis) and the dependence of genotypic effects on environmental
exposure (i.e. gene–environment interactions or plastic reaction
norms) and genotypes at other loci (i.e. gene–gene interactions or
epistasis). Each of these phenomena have been recently reviewed
and discussed by Thornton-Wells et al. (2004) who call for an
analytical retooling to address these complexities. Combining the
complexities summarized here with GWAS data yields signiﬁcant
computational challenges.
To illustrate non-linear mapping from genotype to phenotype,
consider the following example from sporadic Alzheimer disease
(AD). In 2004, Infante et al. (2004) reported that polymorphisms
in the interleukin-6 (IL-6) and interleukin-10 (IL-10) genes had an
interaction effect on the risk of AD. This study of 232 AD patients
and 191 controls reported that patients with the IL-6 C/C and IL-10
A/AgenotypeshadaﬁvetimeslowerriskofADthancontrolsubjects
(P=0.005). What makes this association interesting is the absence
of a statistically signiﬁcant association for the IL-10 A/A genotype
(P=0.102). Further, there is signiﬁcant biological plausibility for
this interaction given the importance of inﬂammation inAD and the
signiﬁcant role of Il-6 as a pro-inﬂammatory molecule and IL-10
as an anti-inﬂammatory molecule. Of course, the gold standard
in genetic association studies is replication. In 2009, Combarros
et al. (2009) replicated the interaction of the IL-6 and IL-10 genes
in a collaboration of seven AD studies with a total of 1757 AD
cases and 6295 controls. The statistical replication of the non-linear
interaction and the biological plausibility of the ﬁnding strongly
suggest that these two genetic markers or nearby markers contribute
to the development of AD.
Moore and Ritchie (2004) have provided an overview of
three signiﬁcant challenges that must be overcome if we are to
successfully identify those genetic variations that are associated
with health and disease using a genome-wide approach. First,
powerful data mining and machine learning methods will need to
be developed to computationally model the relationship between
combinations of SNPs, other genetic variations and environmental
exposure with disease susceptibility. This is because traditional
parametric statistical approaches such as logistic regression have
limited power for modeling high-order non-linear interactions
that are likely important in the etiology of complex diseases
(Moore and Williams, 2002). A second challenge is the selection
of SNPs that should be included in the analysis. If non-linear
interactions between genes explain a signiﬁcant proportion of
the heritability of common diseases, then combinations of SNPs
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will need to be evaluated from a list of thousands or millions
of candidates. Filtering algorithms and/or stochastic search or
wrapper algorithms will play an important role in GWAS because
there are more combinations of SNPs to examine than can be
exhaustively evaluated using modern computational horsepower. A
third challenge is the biological interpretation of non-linear genetic
models. Even when a computational model can be used to identify
SNPs with genotypes that increase susceptibility to disease, the
speciﬁcs of the mathematical relationships cannot be translated into
prevention and treatment strategies without interpreting the results
in the context of human biology. Making etiological inferences from
computational models may be the most important and the most
difﬁcult challenge of all (Moore and Ritchie, 2004).
2.2 The modeling challenge
The parametric linear statistical model plays a very important role
in modern genetic epidemiology because it has solid theoretical
foundation, is easy to implement using a wide range of different
software packages such as SAS and R and is easy to interpret.
Despite these good reasons to use linear models, they do have
limitations for detecting non-linear patterns of interaction (Moore
and Williams, 2002). In addition, they are not likely to explain a
large part of the variance of any given trait (Moore, 2003) which
may explain some of the missing heritability that has not been
accountedforbyGWAS(Manolioetal.,2009).Theﬁrstissueisthat
statistical or computational modeling of non-linear interactions and
other complex phenomena such as locus heterogeneity inherently
requires looking at combinations of SNPs. Considering multiple
SNPs simultaneously is analytically challenging because the study
samples or instances get spread thinly across multiple combinations
of genotypes. This is because the number of genotype combinations
goesupexponentiallyaseachSNPisaddedtothemodel.Estimation
ofparametersinalinearmodelcanbeproblematicwherenodataare
observed for individual genotype combinations (i.e. empty cells).
The second issue is that parametric linear models are generally
implemented such that interaction effects are only modeled using
factors that exhibit independent marginal effects. This makes model
ﬁtting easier but implicitly assumes that genetic architecture is
simple and that important predictors will have detectable marginal
effects. Further, it is well documented that linear models have
greaterpowertodetectmarginaleffectsthaninteractions(Lewontin,
1974; Wahlsten, 1990). For example, the focused interaction testing
framework (FITF) approach of Millstein et al. (2006) provides
a powerful logistic regression approach to detecting interactions
but conditions on marginal effects. Interactions in the absence of
signiﬁcant marginal effects are missed by FITF and other similar
methods.
How common are gene–gene interactions in the absence of
signiﬁcant marginal effects likely to be? Moore (2003) argues that
a simple genetic architecture characterized by SNPs with large
marginal effects is an unrealistic assumption for many common
human diseases. Rather, it is likely that complex phenomena such as
epistasisorgene–geneinteractionswillmakeupmuchofthegenetic
architecture.AsMoore(2003)summarizes,thereareseveralreasons
for this. First, epistasis is on old idea that has been around since the
early 1900s. Early geneticists such as Bateson (1909) recognized
the importance of gene–gene interactions for explaining deviations
from Mendelian patterns of inheritance. More important than this
historical note is the fact that epistasis is still discussed today as a
key component of genetic architecture. Second, biological systems
are driven by complex biomolecular interactions. As such, it makes
sense that gene–gene interactions would play an important role in
the genotype to phenotype mapping relationship. Studies emerging
fromthegeneticanalysisofbacteriaandyeastdocumentwidespread
epistasis at the biological level. Third, single SNP results do not
always replicate even if cases where there is a general consensus
that the association signal is real. This has been the norm for GWAS
where very few SNPs with signiﬁcant marginal effects replicate in
multiple independent samples.As Marchini et al. (2005) and Greene
et al. (2009c) suggest, this may be partly due to underlying patterns
of epistasis. Finally, epistasis is commonly found when properly
investigated (Templeton, 2000). Studies that look for gene–gene
interactions in a manner that does not condition on marginal effects
commonly ﬁnd such non-linear effects. We predict that the data
mining and machine learning methods reviewed here will reveal
numerous signiﬁcant interactions and other complex genotype–
phenotype relationships when they are widely applied to GWAS
data.
Thelimitationsofthelinearmodelandotherparametricstatistical
approaches have motivated the development of data mining and
machine learning methods (e.g. Hastie et al., 2009; Mitchell, 1997).
The advantage of these computational approaches is that they make
fewer assumptions about the functional form of the model and the
effects being modeled (McKinney et al., 2006). In other words, data
mining and machine learning methods are much more consistent
with the idea of letting the data tell us what the model is rather
than forcing the data to ﬁt a preconceived notion of what a good
model is. Several recent reviews highlight the need for new methods
(Thornton-Wells et al., 2004) and discuss and compare different
strategiesfordetectingstatisticalepistasis(Cordell,2009;Motsinger
et al., 2007). The methods reviewed by Cordell (2009) include
novel approaches such as combinatorial partitioning (Culverhouse
et al., 2004; Nelson et al., 2001) and logic regression (Kooperberg
et al., 2001; Kooperberg and Ruczinski, 2005) and machine learning
approaches such as random forests (RFs). Below, we brieﬂy
review two of these methods, RFs and multifactor dimensionality
reduction (MDR) that have been developed to address these issues.
Importantly, as Marchini et al. (2005) demonstrated, interaction
analysis can have more power than traditional approaches despite
issues such as multiple testing. This study provides an important,
but often overlooked, foundation for the methods described below.
2.3 Computational modeling using decision trees
and RFs
Classiﬁcation or decision trees are a staple in the data mining and
machine learning community due to their algorithmic simplicity and
ease of interpretation. Decision trees are widely used for modeling
the relationship between one or more attributes and a discrete end
point such as case–control status (Mitchell, 1997). Here, we use the
word attribute to mean a variable such as a SNP or a demographic
variable such as gender that is used to make a prediction. Attribute
is commonly used this way in data mining and machine learning.
In statistics, an attribute is an independent variable, explanatory
variable or predictor. A decision tree classiﬁes subjects as case or
control by sorting them through a tree from node to node where
each node is an attribute with a decision rule that guides that subject
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Fig. 1. Overview of the RF algorithm summarized in Section 2.3. Adapted
from Reif et al. (2006).
through different branches of the tree to a leaf that provides its
classiﬁcation. The primary advantage of this approach is that it
is simple and the resulting tree can be interpreted as a series of
IF-THEN rules that are easy to understand. For example, a genetic
model of heterozygote effects with genotype data coded {AA=0,
Aa=1,aa=2} might look like IF genotype at SNP1=1 THEN case
ELSE control. In this simple model, the root node of the tree would
be SNP1 with decision rule ‘= 1’and leafs equal to case and control
(e.g. see tree in Fig. 1). Additional nodes or attributes below the
root node allows hierarchical dependencies (i.e. interactions) to be
modeled. Here, we review RFs that extend decision trees for the
analysis of more complex data.
A RF is a collection of individual decision tree classiﬁers, where
each tree in the forest has been trained using a bootstrap sample of
instances(i.e.subjects)fromthedata,andeachattributeinthetreeis
chosen from among a random subset of attributes (Breiman, 2001).
Classiﬁcation of instances is based upon aggregate voting over all
trees in the forest.
Individual trees are constructed as follows from data having N
samples and M attributes:
(1) Choose a training set by selecting N samples, with
replacement, from the data.
(2) At each node in the tree, randomly select m attributes from
the entire set of M attributes in the data (the magnitude of m
is constant throughout the forest building).
(3) Choosethebestsplitatthatnodefromamongthem attributes.
(4) Iterate the second and third steps until the tree is fully grown
(no pruning).
Repetition of this algorithm yields a forest of trees, each of which
have been trained on bootstrap samples of instances. Thus, for a
given tree, certain samples or instances will have been left out
during training. Prediction error is estimated from these ‘out-of-
bag’ instances. The out-of-bag instances are also used to estimate
the importance of particular attributes via permutation testing. If
randomly permuting values of a particular attribute does not affect
the predictive ability of trees on out-of-bag samples, that attribute
is assigned a low importance score (Bureau et al., 2005).
RFs are often used initially for selecting the subset of attributes
that can then be modeled using a decision tree. We discuss using
algorithms such as RF for ﬁltering subsets of SNPs later in
Section 2.6. An advantage of the RF approach is that the ﬁnal
decision tree models may uncover interactions among genes and/or
environmental factors that do not exhibit strong marginal effects
(Cook et al., 2004), especially when combined with methods such
as ReliefF (see Section 2.6) for choosing the attributes to be used
as nodes. Additionally, tree methods are suited to dealing with
certain types of genetic heterogeneity, since early splits in the tree
deﬁne separate model subsets in the data (Lunetta et al., 2004). RFs
capitalize on the beneﬁts of decision trees and have demonstrated
excellent predictive performance when the forest is diverse (i.e.
trees are not highly correlated with each other) and composed of
individually strong classiﬁer trees (Breiman, 2001). The RF method
is a useful approach for studying gene–gene or gene–environment
interactions because importance scores for particular attributes take
interactions into account without demanding a prespeciﬁed model
(Lunetta et al., 2004). However, most current implementations of
the importance score are calculated in the context of all other
attributesinthemodel.Therefore,assessingtheinteractionsbetween
particular sets of attributes must be done through careful model
interpretation,althoughtherehasbeenpreliminarysuccessinjointly
permuting explicit sets of attributes to capture their interactive
effects (Bureau et al., 2005).
Lunetta et al. (2004) have previously shown that RFs outperform
traditional methods such as the Fisher’s exact test when the ‘risk’
SNPs interact. This study revealed that the relative superiority of
the RF method increases as more interacting SNPs are added to
the model. In addition, Bureau et al. (2005) have shown that RFs
are robust in the presence of noisy or potential false positive SNPs
relative to methods that rely on independent marginal effects. Initial
results of RF applications to genetic data in studies of asthma
(Bureau et al., 2005), rheumatoid arthritis (Sun et al., 2007) and
glioblastoma (Chang et al., 2008), age-related macular degeneration
(Jiangetal.,2009)andvaccinationresponse(McKinneyetal.,2009)
are encouraging and it is anticipated that RF will prove a useful tool
for detecting gene–gene interactions. They may also be useful when
multiple different data types (e.g. proteomic biomarkers) are present
(Reif et al., 2006, 2009) or for inferring gene networks (McKinney
et al., 2009). The primary limitation of tree-based methods is that
the standard implementations condition on marginal effects. That
is, the algorithm ﬁnds the best single variable for the root node
beforeaddingadditionalvariablesasnodesinthemodel.Combining
RF with ReliefF methods (described below) shows potential for
overcoming this limitation (McKinney et al., 2009). Advantages of
this approach include its basis on decision trees and the availability
of the algorithm in many different open source software packages
including R. In fact, the Willows package was designed speciﬁcally
for tree-based analysis of SNP data (Zhang et al., 2009).
2.4 Computational modeling using MDR
Thornton-Wells et al. (2004) review the complex nature of the
genotype–phenotype relationship and suggest that we need new
statistical and computational tools to address these complexities.
As a result, there is growing trend toward the development and
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Fig. 2. Summary of the constructive induction process for MDR. The left
bars within each cell represent the number of cases while the right bars
represent the number of controls. Dark-shaded cells are high risk while the
light-shaded cells are low risk. Prediction using any classiﬁer can be carried
out using the ﬁnal constructed attribute.
evaluation of new and novel approaches that have more power
for modeling non-linearity than parametric statistical approaches.
As Cordell (2009) recently summarized, MDR is an example of
one novel computational strategy for detecting and characterizing
non-linear patterns of gene–gene interactions in genetic association
studies.MDRwasdevelopedasanon-parametric(i.e.noparameters
are estimated) and genetic model-free (i.e. no genetic model is
assumed) data mining and machine learning strategy for identifying
combinations of discrete genetic and environmental factors that are
predictive of a discrete clinical end point (Hahn et al., 2003; Moore,
2004, 2007b; Moore and Hahn, 2004; Moore and White, 2006;
Ritchie et al., 2001, 2003). Unlike most other methods, MDR was
designed to detect interactions in the absence of detectable marginal
effects and thus complements statistical approaches such as logistic
regression and machine learning methods such as RFs and neural
networks.
At the heart of the MDR approach is a feature or attribute
construction algorithm that creates a new variable or attribute by
pooling genotypes from multiple SNPs (Moore and White, 2006).
The general process of deﬁning a new attribute as a function
of two or more other attributes is referred to as constructive
induction, or attribute construction, and was ﬁrst described by
Michalski (1983). Constructive induction, using the MDR kernel,
is accomplished in the following way (Fig. 2). Given a threshold T,
amultilocusgenotypecombinationisconsideredhighriskiftheratio
ofcases(subjectswithdisease)tocontrols(healthysubjects)exceeds
T, otherwise it is considered low risk. Genotype combinations
consideredtobehighriskarelabeledG1 whilethoseconsideredlow
risk are labeled G0. This process constructs a new one-dimensional
attribute with values of G0 and G1. It is this new single variable
that is assessed, using any classiﬁcation method. The MDR method
is based on the idea that changing the representation space of the
data will make it easier for methods such as logistic regression,
classiﬁcation trees or a naive Bayes classiﬁer to detect attribute
dependencies. As such, MDR signiﬁcantly complements other
classiﬁcation method such as those reviewed by Hastie et al. (2001).
Thismethodhasbeenconﬁrmedinnumeroussimulationstudiesand
a user-friendly open source MDR software package written in Java
is freely available from www.epistasis.org.
Since its initial description by Ritchie et al. (2001), many
modiﬁcations and extensions to MDR have been proposed. These
include entropy-based interpretation methods (Moore and White,
2006),theuseofoddsratios(Chungetal.,2007),log-linearmethods
(Lee et al., 2007), generalized linear models (Lou et al., 2007),
methods for imbalanced data (Velez et al., 2007), permutation
testing methods (Greene et al., 2010a; Pattin et al., 2009), methods
for dealing with missing data (Namkung et al., 2009a), model-
based methods (Calle et al., 2008), parallel implementations (Bush
et al., 2006; Sinnott-Arnstrong et al., 2009) and different evaluation
metrics (Bush et al., 2008; Mei et al., 2007; Namkung et al.,
2009b). These extensions have addressed many of the previous
limitations of the MDR method. The MDR approach has also been
successfully applied to a wide range of different genetic association
studies. For example, Andrew et al. (2006) used MDR to model
the relationship between polymorphisms in DNA repair enzyme
genes and susceptibility to bladder cancer.Ahighly signiﬁcant non-
additive interaction was found between two SNPs in the Xeroderma
pigmentosum group D (XPD) gene that was a better predictor
of bladder cancer than smoking. Importantly, these results have
been independently replicated (International Consortium of Bladder
Cancer, 2009).
2.5 The attribute selection challenge
Combining the complexity of the genotype–phenotype relationship
described above with the challenge of attribute (e.g. SNP) selection
yields a needle-in-a-haystack problem. That is, there may be a
particular combination of SNPs or SNPs and environmental factors
that together with the right non-linear function are a signiﬁcant
predictorofdiseasesusceptibility.However,individuallyeachfactor
may not appear different than thousands of other SNPs that are not
involved in the disease process and are thus noisy. Therefore, the
learning algorithm is truly looking for a genetic needle in a genomic
haystack. It is now commonly assumed that at least 106 carefully
selectedSNPsarenecessarytocapturemuchoftherelevantvariation
across the human genome. With this many attributes, the number of
higher order combinations is astronomical. These large datasets beg
the question, what is the optimal computational approach to this
problem?
There are two general approaches to selecting attributes for
predictive models. The ﬁlter approach preprocesses the data by
algorithmically assessing the quality or relevance of each variable
and then using that information to select a subset for analysis.
The wrapper approach iteratively selects subsets of attributes for
classiﬁcation using either a deterministic or stochastic algorithm.
The key difference between the two approaches is that the learning
algorithmplaysnoroleinselectingthoseattributestoconsiderinthe
ﬁlter approach.As Freitas (2002) reviews, the advantage of the ﬁlter
is speed while the wrapper approach has the potential to do a better
job classifying subjects as sick or healthy. We ﬁrst discuss several
learningalgorithmsthathavebeenappliedtoclassifyinghealthyand
disease subjects using their DNA sequence information and then
discuss ﬁlter and wrapper approaches for the speciﬁc problem of
detecting epistasis or non-linear patterns of gene–gene interactions
on a genome-wide scale.
2.6 Attribute selection using ﬁlter algorithms
As discussed above, it is computationally infeasible to com-
binatorially explore all high-order interactions among the SNPs
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in a genome-wide association study. One approach is to ﬁlter out
a subset of genetic variations with high quality (i.e. likely to be
associated) that can then be efﬁciently analyzed using a method
such as RFs or MDR (Moore and White, 2006; Wilke et al., 2005).
There are many different statistical and computational methods for
determining the quality of attributes. A standard statistical strategy
in human genetics and genetic epidemiology is to assess the quality
of each SNP using a chi-square test of independence followed
by a correction of the signiﬁcance level that takes into account
an increased false positive (i.e. type I error) rate due to multiple
tests. This is a very efﬁcient ﬁltering method for assessing the
independent effects of SNPs on disease susceptibility but it ignores
the dependencies or interactions between genes.
Kira and Rendell (1992) developed an algorithm called Relief
that is capable of detecting complex attribute dependencies even
in the absence of marginal effects. Relief estimates the quality of
attributes through a type of nearest neighbor algorithm that selects
neighbors (instances) from the same class and from the different
classbasedonthevectorofvaluesacrossattributes.Forthepurposes
ofthisdescription,weassumetheclassisdichotomous.Weights(W)
or quality estimates for each attribute (A) are estimated based on
whether the nearest neighbor (nearest hit, H) of a randomly selected
instance (R) from the same class and the nearest neighbor from the
other class (nearest miss, M) have the same or different values.
This process of adjusting weights is repeated for m instances.
The algorithm produces weights for each attribute ranging from
−1(worst)to+1(best).ThetimecomplexityofReliefisO(m∗n∗a)
wheremisthenumberofinstancesrandomlysampledfromadataset
with n total instances and a attributes. Kononenko (1994) improved
upon Relief by choosing n (usually set to 10) nearest neighbors
instead of just one. This new ReliefF algorithm has been shown
to be more robust to noisy attributes (Kononenko, 1994; Robnik-
Šikonja and Kononenko, 2003) and is widely used in data mining
applications.
ReliefF is able to capture attribute interactions because it selects
nearest neighbors using the entire vector of values across all
attributes. However, this advantage is also a disadvantage because
the presence of many noisy or potential false positive attributes can
reduce the signal the algorithm is trying to capture. Moore and
White (2007b) proposed a ‘tuned’ ReliefF algorithm (TuRF) that
systematically removes attributes that have low-quality estimates so
thattheReliefFvaluesiftheremainingattributescanbereestimated.
The motivation behind this algorithm is that the ReliefF estimates
of the true functional attributes will improve as the noisy attributes
are removed from the dataset. Moore and White (2007b) carried
out a simulation study using previously published epistasis models
(Velez et al., 2007) to evaluate the power of ReliefF, TuRF and
a naïve chi-square test of independence for selecting functional
attributes in a ﬁltered subset. Moore and White (2007b) found
that the power of ReliefF to pick (ﬁlter) the correct interacting
attributes was consistently better (P≤0.05) than a naïve chi-square
test of independence and that the TuRF algorithm was consistently
better (P≤0.05) than ReliefF across all models studied. More
recent extensions of the ReliefF algorithm have shown that using
higher numbers of nearest neighbors greatly improve the power of
ReliefF. For example, Greene et al. (2009b) showed that a spatially
uniform ReliefF (SURF) that picks all neighbors within a predeﬁned
epsilon (i.e. distance or radius) greatly improves the power to detect
interacting SNPs over that of ReliefF. McKinney et al. (2007) have
Fig. 3. Summary of how Relief, ReliefF and SURF select neighbors. Each
panel in this ﬁgure shows the genotypes at two markers for a dataset of cases
and controls. For the purpose of this example only these two markers will be
considered and both are continuous. When analyzing real data, the process
of selecting neighbors is the same, however, but there will be thousands of
discrete valued markers (SNPs) each of which would be represented by one
of thousands of dimensions. The individual for whom neighbors are being
foundisshownbytheﬁlledredcircle.Theneighborsthateachapproachuses
for weighting are highlighted in blue. (A–C) Represent how Relief, ReliefF
and SURF would select neighbors to be used in weighting. Relief selects the
nearestindividualofthesamedichotomousclass(bluecircle)andthenearest
individual of the other class (blue cross). ReliefF selects some user speciﬁed
number of individuals (two in this example) to be used for weighting. SURF,
instead of using a ﬁxed number of neighbors, uses all individuals within a
distance threshold. The dotted line shows a hypothetical distance threshold.
combined ReliefF with measures of entropy to yield evaporative
cooling ReliefF. This approach was highly successful when used
to select SNPs for a RFs analysis (McKinney et al., 2009). The
differences between how Relief, ReliefF and SURF select nearest
neighbors are summarized in Figure 3. When combined with
permutation tests designed to assess interactions, P-values can also
be used to select SNPs with signiﬁcant ReliefF scores (Greene
et al., 2010b; Wongseree et al., 2009). These results suggest that
algorithms based on ReliefF show promise for ﬁltering interacting
SNPs. The disadvantage of the ﬁlter approach is that important
attributes might be discarded prior to analysis. Stochastic wrapper
methods provide a ﬂexible alternative and may be more powerful
when the assumptions of the ﬁlter approach are not valid (Greene
et al., 2009a).
2.7 Attribute selection using wrapper algorithms
Wrapper methods may be more powerful than ﬁlter approaches
because no attributes are discarded in the process.As a result, every
attribute retains some probability of being selected for evaluation
by the classiﬁer. There are many different stochastic wrapper
algorithms that can be applied to this problem (e.g. Michalewicz and
Fogel, 2004). We review here evolutionary computing algorithms
as an example stochastic search algorithm that has been developed
for genetic association studies. Ritchie et al. (2003) and Moore
et al. (2007), for example, have explored the use of a type of
evolutionarycomputingalgorithmcalledgeneticprogramming(GP)
for modeling and attribute selection in genetic association studies.
GP is an automated computational discovery tool that is inspired
by Darwinian evolution by natural selection (Banzhaf et al., 1998;
Koza, 1992). The goal of GP is to ‘evolve’ computer programs to
solve complex problems. This is accomplished by ﬁrst generating
or initializing a population of random computer programs that
are composed of the basic building blocks needed to solve or
approximate a solution to the problem. For genetic association
studies this might be a list of SNPs, other important attributes such
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Fig. 4. Flowchart for a simple GP. The goal is to randomly generate an
initial population of computer programs or solutions (e.g. genetic models),
determine their ﬁtness, select the best models, introduce variability and then
iterate until the termination criteria are satisﬁed. This executes a parallel
stochastic search using the principles of evolution by natural selection.
as age and gender along with a list of mathematical functions.
Each randomly generated program is evaluated and the good
programs are selected and recombined and mutated to form new
computer programs. This process of selection based on ﬁtness and
recombinationtogeneratevariabilityisrepeateduntilabestprogram
or set of programs is identiﬁed. A ﬂowchart for a simple GP is
illustrated in Figure 4. GPand its many variations have been applied
successfully in a wide range of different problem domains including
bioinformatics (e.g. Fogel and Corne, 2003) and the genetic analysis
of epistasis (Moore et al., 2007; Ritchie et al., 2003). It is important
to note that GP differs considerably from genetic algorithms (GAs)
in that the solution to a problem in GP is represented by a computer
program rather than a linear bit string. This provides GPa great deal
more ﬂexibility than GA for both attribute selection and modeling.
Consider, for example, the use of GP for attribute selection.
Although we focused on GP here, a GA would likely work just as
well if attribute selection is the only task. Moore and White (2007a)
developed and evaluated a simple GPwrapper for attribute selection
in the context of an MDR analysis. The goal of this study was to
develop a stochastic wrapper method that is able to select attributes
that interact in the absence of independent marginal effects. At face
value, there is no reason to expect that a GP or any other wrapper
method would perform better than a random attribute selector
because there are no ‘building blocks’ for gene–gene interactions
in the absence of marginal effects when accuracy is used as the
ﬁtness measure. That is, the ﬁtness of any given classiﬁer would
look no better than any other when just one of the correct SNPs is in
the MDR model. Preliminary studies by White et al. (2005) support
this idea. For GP or any other wrapper to work there need to be
recognizable building blocks. Moore andWhite (2007a) speciﬁcally
evaluatedwhetherincludingpreprocessedattributequalityestimates
usingTuRF(seeabove)inamultiobjectiveﬁtnessfunctionimproved
attribute selection over a random search that just uses accuracy
as the ﬁtness of the models. Using a wide variety of simulated
data, Moore and White (2007a) demonstrated that including TuRF
scores in addition to accuracy in the ﬁtness function signiﬁcantly
improved the power of GP to pick the correct two functional
SNPs out of 1000 total SNPs. The use of expert knowledge to
guide GP population initialization (Greene et al., 2009d), mutation
(Greene et al., 2007), recombination (Moore andWhite, 2006) and a
computational evolution system (Greene et al., 2010b; Moore et al.,
2008) have also all shown promise. There may also be an important
role for linkage disequilibrium in providing missing building blocks
(Bush et al., 2009).
3 BIOLOGICAL KNOWLEDGE DATABASES FOR
ANALYSIS AND INTERPRETATION
ReliefF and other measures such as interaction information (Moore
andWhite,2006)arelikelytobeveryusefulforprovidinganalytical
means for ﬁltering genetic variations prior to epistasis analysis
using either RFs or MDR, for example. However, there is growing
recognition that we should also use the wealth of accumulated
knowledgeaboutgenefunctiontoprioritizewhichgeneticvariations
are analyzed for gene–gene interactions and other complex effects.
For example, for any given disease there are often multiple
biochemical pathways that have been experimentally conﬁrmed to
play an important role. Genes in these pathways can be selected
for gene–gene interaction analysis thus signiﬁcantly reducing the
number of gene–gene interaction tests that need to be performed.
Gene Ontology (GO), chromosomal location and protein–protein
interactions are all example sources of expert knowledge that can
be used in a similar manner.
Consider for example, the recent studies by Pattin et al. (2008,
2009) who have speciﬁcally reviewed protein–protein interaction
databases as a source of expert knowledge that can be used to
guide GWASs of epistasis. Here, you might expect that a gene
coding for a protein that interacts with many other proteins might
be a good candidate for interaction with one or more other genes.
You could use this information in several different ways. First,
you could employ a biological ﬁlter and only test for interactions
among SNPs in those genes with many protein–protein interactions.
Alternatively, you could weight each gene by its degree of protein–
proteininteractionandthenusethisexpertknowledgeinastochastic
wrapper algorithm. Of course, the most interesting genes might be
those with fewer connections. In this case, you could use the inverse
of the connectedness as your expert knowledge. Some might ﬁnd it
more useful to use the strength of the protein–protein interaction
evidence rather than the number of connections. Here, the genes
could be prioritized or weighted by their conﬁdence score that
reﬂects the quality of the experimental and computational evidence
for their biochemical interaction with other protein products.
The important consideration when using expert knowledge from
biological databases is to harness this information in a way that
makes sense to the biologist. Emily et al. (2009) demonstrate how
protein–protein interactions were used to reduce the search for
two-locus interactions using GWAS data from the Wellcome Trust
Case-Control Consortium.
The use of expert knowledge from GO and biochemical pathways
in GWAS has been recently investigated by a number of groups.
For example, Baranzini et al. (2009), Bush et al. (2009), Elbers
et al. (2009), Emily et al. (2009), Herold et al. (2009), Holmans
et al. (2009), Medina et al. (2009), O’Dushlaine et al. (2009), Pan
(2008),Pengetal.(2009),Sacconeetal.(2008)andTorkamanietal.
(2008) have all shown that using biological knowledge to guide
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genetic association studies may provide more meaningful results.
Yu et al. (2009) provide a hypothesis testing framework for
combining multiple SNPs from the same gene or from multiple
genes in a pathway-based manner. Askland et al. (2009) recently
showed that patterns of SNPs in biological pathways are more likely
toreplicatethanindividualSNPsinGWAS.Thisishighlyconsistent
with the idea that interactions may be more important that marginal
effects. Zamar et al. (2009) have provided a software tool called
Path to assist with pathway-based analysis of SNPs. Wilke et al.
(2008) have suggested that we should not even begin to analyze a
GWAS until we have exhaustively studied each candidate gene and
each pathway. The use of pathways and other biological knowledge
to guide GWAS is an important emerging area and is gaining more
attention at international conferences (Moore, 2009).
Perhaps the greatest challenge of any data mining exercise is
interpreting the results. This is especially important in GWAS
where biological plausibility helps give increased credibility to
results (Greene et al., 2009c; Moore andWilliams, 2005).Assessing
biological plausibility, however, is difﬁcult without software that
can only be generated through collaboration among geneticists
and bioinformaticists. Fortunately, there are a number of emerging
software packages that are designed with this in mind. GenePattern,
for example, provides an integrated set of analysis tools and
knowledge sources that facilitates this process (Reich et al., 2006).
Other tools such as the exploratory visual analysis database and
software are designed speciﬁcally for integrating research results
with biological knowledge from public databases (Reif et al., 2005)
and have been applied to GWAS data (Askland et al., 2009).
Several commercial packages for typing bioinformatics results to
pathways and gene function include Pathway Studio from Ariadne
andIngenuityPathwayAnalysisfromIngenuitySystems.Ontology-
based methods (Tsoi et al., 2009) and literature-based systems (Yu
et al., 2008) have also been recently proposed for aiding with
interpretation.
The use of biological knowledge in genetic association studies
does have some important limitations. First, success is highly
dependent on the quality of the information in the databases.
In assessing quality, we need to consider both accuracy of the
information included and the completeness of the information. Our
expectation is that the quality and completeness of the databases
will continue to improve and the amount of good information will
soon outweigh the bad. This of course depends critically on the both
the throughput and quality of experimental methods used to reveal
molecular details and their relationships. Second, it is important to
keep in mind the disconnect between the biology that happens at
the cellular level and the statistical patterns of genetic variation that
we observe at the population level (Moore andWilliams, 2005). It is
very difﬁcult to make inference about population-level risk from the
knowledge of cellular function and vice versa. This will always to
some degree limit our ability to use biological knowledge to assist
with association studies in human populations.
4 SOFTWARE CHALLENGES
Perhaps the biggest challenge moving forward with GWAS analysis
is to facilitate communication at all levels among biomedical
researchers, biostatisticians and computer scientists. The key
to successful bioinformatics is close face-to-face collaboration
between the biologist, biostatistician and bioinformaticist. This is
not always possible due to distances between institutions but is
critical for moving forward with a systems-based research agenda
where large volumes of data and information are the norm. The best
bioinformatics tools will be those that experts in each area can use
jointly.
We propose that one way to facilitate the close collaboration
between biologists, biostatisticians and bioinformaticists is to make
available user-friendly software packages that can be used jointly by
researchers with expertise in experimental biology and researchers
with expertise in statistics and computer science (Moore, 2007a).
This will require software that is intuitive enough for a biologist
and powerful enough for an analyst. To be intuitive to a biologist,
the software needs to be easy to use and needs to provide output
that is visual and easy to navigate. To be powerful, the software
needs to provide the functionality that would allow a biostatistician
and a bioinformaticist the ﬂexibility to explore the more theoretical
aspects of the algorithm. The key, however, to the success of any
such software package is the ability of the biologist and the analysts
to sit down together at the computer and jointly carry out an
analysis. This is important for several reasons. First, the biologist
can help answer questions the analyst might have that are related
to domain-speciﬁc knowledge. Such questions might only arise at
the time of the analysis and might otherwise be ignored. Similarly,
the biologist might have ideas about speciﬁc questions to address
with the software that might only be feasible with the help of the
analyst. For example, a question that requires multiple processors
to answer might need the assistance of someone with expertise in
parallel computing.
The idea that biologists and analysts should work together
is not new. Langley (2002) has suggested ﬁve lessons for the
computational discovery process. First, traditional computational
notations are not easily communicated to biologists. This is
important because a computational model may not be interpretable
by a biologist. Second, biologists often have initial models that
should inﬂuence the discovery process. Domain-speciﬁc knowledge
such as details about enzymatic reactions in a biochemical pathway
can be critical to the discovery process. Third, biological data are
often rare and difﬁcult to obtain. It often takes years to collect
and process the data to be analyzed. As such, it is important that
the analysis is carefully planned and executed. Fourth, biologists
want models that move beyond description to provide explanation
of data. Explanation and interpretation are paramount to the
biologist. Finally, biologists want computational assistance rather
than automated discovery systems. Langley (2002) suggests that
practitioners want interactive discovery environments that help
them understand their data while at the same time giving them
or their collaborating analyst control over the modeling process.
Collectively, these ﬁve lessons suggest that synergy between
biologists and bioinformaticists is critical. This is because each has
important insights that may not get expressed or incorporated into
the discovery process if either carries out the analysis in isolation.
Future bioinformatics databases and analysis tools that successfully
integrate these lessons will prove to be the most useful for GWAS
and other high-throughput approaches.
5 SUMMARY AND CONCLUSIONS
Figure 5 summarizes a bioinformatics analysis strategy for GWAS
based on the challenges outlined here. As discussed, it is important
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Fig. 5. Flowchart for bioinformatics analyses of GWAS data. The use of
ﬁlterandwrapperalgorithmsalongwithcomputationalmodelingapproaches
is recommended in addition to parametric statistical methods. Biological
knowledge in public databases has a very important role to play at all levels
of the analysis and interpretation.
thatbiologicalknowledgeavailableinpublicdatabasesbeintegrated
with GWAS data and clinical data. Following quality control
procedures, available biological knowledge can be used to help
guide both statistical and computational analyses as reviewed
in Section 3. Given the complexity of the genotype–phenotype
mappingrelationship,werecommendtwocomplementarystrategies
for computational analysis. The ﬁrst strategy uses ﬁlter algorithms
(see Section 2.6) such as those based on ReliefF or prior statistical
results to select more manageable subsets of SNPs that can then
be more efﬁciently analyzed using computational methods. The
seconduseswrapperalgorithms(seeSection2.7)basedonstochastic
search methods such as GP for identifying optimal combinations
of SNPs that are associated with disease end points. We suggest
that computational modeling methods such as RF (see Section 2.3)
and MDR (see Section 2.4) are needed to complement parametric
statistical methods such as logistic regression for identifying non-
linear patterns in GWAS data. The challenge of any statistical
or computational analysis is the biological interpretation of a set
of results. Use of prior knowledge about biological systems can
facilitate this process. Once an inference is made and validated, new
knowledge can be contributed to the public knowledge databases
thus enhancing future iterations of this ﬂowchart. We anticipate
that this entire process will be greatly aided by the development
of powerful and user-friendly software that can be optimally used
by biologists, biostatisticians and bioinformaticists (see Section 4).
GWAS have generated a number of important bioinformatics
challenges including the modeling of complex genotype–phenotype
relationships using data mining and machine learning methods,
the use of biological knowledge databases to help guide and
interpret genetic association studies and the development of
powerful and user-friendly software that can facilitate interaction
and collaboration among biologists and bioinformaticists. The
ﬂowchart shown in Figure 5 provides a starting point for the
development of comprehensive and fully informative analyses of
GWAS. This will become especially necessary as we generate more
and more data and discover new complexities in the genome that
make powerful bioinformatics research strategies even more critical
for identifying genetic risk factors for common human diseases.
With whole-genome sequencing on the horizon, we need to recruit
the next generation of bioinformaticists to tackle these and other
important computational challenges in genetic analysis because
agnostic biostatistical approaches will only get us so far.
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